课题基金 / 基金详情

Energy Metabolism Markers of Cognitive Function in Early Psychosis and Risk

Energy Metabolism Markers of Cognitive Function in Early Psychosis and Risk
早期精神病和风险中认知功能的能量代谢标志物
批准号:
10242716
负责人:
Virginie-Anne Chouinard
金额:
$19.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-10 至 2024-08-31
关键词:
Adenosine TriphosphateAntipsychotic AgentsAreaBioenergeticsBiological MarkersBrainCellsClinicalClinical ResearchCognitionCognitiveCognitive deficitsCreatine KinaseCritical IllnessDataData AnalysesDevelopmentEarly InterventionEnergy MetabolismFoundationsFunctional Magnetic Resonance ImagingFutureGeneral HospitalsGeneral PopulationGoalsHeritabilityHospitalsHumanImpaired cognitionImpairmentIndividualInsulinInsulin ResistanceInternationalInterventionKnowledgeLife ExpectancyLinkLongitudinal StudiesMagnetic Resonance SpectroscopyMassachusettsMeasuresMediator of activation proteinMemory impairmentMentored Patient-Oriented Research Career Development AwardMentorshipMetabolicMetabolic PathwayMetabolic dysfunctionMetabolismMethodologyMultimodal ImagingNational Institute of Mental HealthNeuronal DysfunctionNeuronsNon-Insulin-Dependent Diabetes MellitusObesityOutcomePathway interactionsPatient CarePatientsPerformancePharmaceutical PreparationsPhosphocreatinePlayPopulationPrefrontal CortexPreventionProgram DevelopmentPsychiatristPsychiatryPsychosesPsychotic DisordersQuality of lifeResearchResearch PersonnelResearch TrainingResidenciesResourcesRiskRisk ReductionRoleSchizophreniaScientistShort-Term MemorySiblingsSignal TransductionStatistical MethodsTimeTrainingTraining Programscareercareer developmentcognitive functioncognitive loadcognitive neurosciencecognitive processdesigndisabilityexperiencefirst episode psychosisfollow-upfunctional outcomeshigh riskimprovedinnovationinstructorinsulin sensitivityinsulin signalingmedical schoolsmitochondrial dysfunctionneuronal growthneurotransmissionnutritionpatient oriented researchprogramsreaction raterecruitsevere psychiatric disorder

项目摘要

项目成果

Virginie-Anne Chouinard的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT ABSTRACT Background: Evidence points to the importance of early intervention in psychotic disorders to alter illness trajectory and disability. As cognitive deficits and poor functioning are not adequately targeted with current treatment, there is an urgent need to investigate underlying mechanisms of these deficits in early psychosis and risk for psychosis. This K23 application proposes a career development program that incorporates rigorous training with an innovative research agenda aimed at identifying early intervention targets for cognitive deficits in early psychotic illness. Candidate: I am an Instructor in Psychiatry at Harvard Medical School and a psychiatrist specialized in the care of patients with first episode psychosis in the OnTrack Program at McLean Hospital. I am a graduate of the Massachusetts General Hospital/McLean Psychiatry Residency and completed the NIMH T32 Clinical Research Training Program at Harvard Medical School. I have a clinical research background in first episode psychosis and high risk for psychosis. This K23 award will provide me with the support necessary to become an expert in patient-oriented research in psychotic disorders and develop an independent clinical research career. Research: Preliminary evidence shows that energy metabolism is dysfunctional in individuals with first episode psychosis and those at high risk for psychosis. As the human brain is highly metabolically active, metabolic abnormalities may play a key role in the emergence of neuronal dysfunction in psychotic disorders. The proposed research will use 31P magnetic resonance spectroscopy (MRS), functional magnetic resonance imaging (fMRI) and metabolic measures to determine the impact of bioenergetic and insulin abnormalities on cognitive function in patients with first episode psychosis and their unaffected siblings over the course of one-year follow-up. Career development and future program of research: I am proposing to acquire training in the areas of: 1) Cognitive neuroscience, including fMRI; 2) Metabolic signaling in the brain; and 3) Statistical methods for longitudinal data analysis. These goals will be accomplished by formal coursework and mentorship by an exceptionally-qualified team of scientists who are internationally-recognized leaders in research directly relevant to the proposal. Completion of the proposed research and training aims will enable the design of a large-scale longitudinal R01 study aimed at modulating energy metabolism to improve cognition and functioning in early psychosis, while mapping casual pathways using multimodal imaging and metabolic methodology. This K23 proposal will provide the training needed for my development as an independent investigator focused on identifying early intervention targets for cognitive deficits across trajectories of risk and early psychosis. It will provide the foundation for a program of research facilitating the development of personalized clinical interventions to alter the course of early psychotic illness, and ultimately, illness prevention and risk reduction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Energy Metabolism Markers of Cognitive Function in Early Psychosis and Risk
  • 批准号:
    10475107
  • 项目类别:
  • 资助金额:
    $19.31万
  • 财政年份:
    2019
  • 负责人:
    Virginie-Anne Chouinard
  • 依托单位:
Energy Metabolism Markers of Cognitive Function in Early Psychosis and Risk
  • 批准号:
    10015351
  • 项目类别:
  • 资助金额:
    $19.31万
  • 财政年份:
    2019
  • 负责人:
    Virginie-Anne Chouinard
  • 依托单位:
Energy Metabolism Markers of Cognitive Function in Early Psychosis and Risk
  • 批准号:
    10687132
  • 项目类别:
  • 资助金额:
    $19.31万
  • 财政年份:
    2019
  • 负责人:
    Virginie-Anne Chouinard
  • 依托单位:
海外基金